Understand the source comparison
Peptides for Brain Fog Research: Mechanism Comparison
Before selecting peptides for brain fog research, understanding which mechanism each compound targets determines study design, dosing protocols, and expected timeline for observable effects. The following table maps peptide candidates to their primary mechanis
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting peptides for brain fog research, understanding which mechanism each compound targets determines study design, dosing protocols, and expected timeline for observable effects. The following table maps peptide candidates to their primary mechanisms, typical research dosing ranges, and key differentiators.
- Cerebrolysin
- Neuroprotection via microglial modulation
- 10–30 mL (peptide mixture) per protocol session
- 2–3 hours
- Multi-peptide mixture with established clinical trial data in stroke and TBI models
- Best choice for neuroinflammation-driven cognitive impairment research with robust human data
- Semax Amidate
- BDNF upregulation + enkephalinase inhibition
- 300–600 mcg daily
- 20–30 minutes
- Dual mechanism addressing both neuroplasticity and stress response
- Ideal for models where stress-induced cognitive decline is the primary variable
- Dihexa
- HGF mimetic promoting synaptogenesis
- 0.5–5 mg/kg (preclinical models)
- 2–4 hours
- Orally bioavailable, targets structural neuroplasticity
- Most promising for synapse loss models; limited human data as of 2026
- MOTS-C
- Mitochondrial biogenesis via AMPK activation
- 5–15 mg per administration
- 1–2 hours
- Mitochondrial-derived peptide targeting energy metabolism
- First-line candidate for metabolic or age-related cognitive decline models
- P21
- Hippocampal neurogenesis + AMPA receptor trafficking
- 1–5 mg/kg (preclinical)
- 3–5 hours
- Selective enhancement of pattern separation
- Best for memory consolidation and recall precision studies
- Selank Amidate
- Anxiolytic + BDNF modulation
- 300–900 mcg daily
- Addresses anxiety-driven cognitive interference
- Strongest evidence in anxiety-comorbid cognitive impairment models
- Mechanism overlap exists. Semax and Selank both upregulate BDNF but through different receptor pathways. Combining peptides in research protocols is common but requires understanding pharmacodynamic interactions. Cerebrolysin's multi-peptide composition makes stacking with single-target peptides complex. Overlapping pathways can produce synergy or ceiling effects depending on dose timing.